Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

GM INTERVENTIONAL ONCOLOGY

GEN'L COUNSEL, CCO & SECY

CHIEF EXECUTIVE OFFICER

CHIEF MEDICAL OFFICER

SVP OF FINANCE, PFO AND PAO

Chief Medical Officer

Chief Executive Officer

SVP of Finance, PFO and PAO

See Remarks

Chief Operating Officer

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with hepatic dominant ocular melanoma to investigate objective response rate in metastatic ocular melanoma. The company also provides HEPZATO as a stand-alone medical device for sale under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-19	Premium	acquired	Premium	Premium	Premium	GM INTERVENTIONAL ONCOLOGY
2024-03-19	Premium	acquired	Premium	Premium	Premium	GEN'L COUNSEL, CCO & SECY
2024-03-19	Premium	acquired	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-03-19	Premium	bought	Premium	Premium	Premium	-
2024-03-19	Premium	acquired	Premium	Premium	Premium	CHIEF MEDICAL OFFICER
2024-03-19	Premium	acquired	Premium	Premium	Premium	SVP OF FINANCE, PFO AND PAO
2024-03-19	Premium	bought	Premium	Premium	Premium	-
2023-12-12	Premium	bought	Premium	Premium	Premium	Chief Medical Officer
2023-12-08	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2023-11-17	Premium	bought	Premium	Premium	Premium	-
2023-11-17	Premium	bought	Premium	Premium	Premium	SVP of Finance, PFO and PAO
2023-11-16	Premium	bought	Premium	Premium	Premium	See Remarks
2023-11-16	Premium	bought	Premium	Premium	Premium	Chief Medical Officer
2023-10-13	Premium	bought	Premium	Premium	Premium	Chief Operating Officer
2023-08-21	Premium	bought	Premium	Premium	Premium	-
2023-08-18	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-03-29	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2022-12-14	Premium	bought	Premium	Premium	Premium	-
2022-12-14	Premium	bought	Premium	Premium	Premium	-
2022-12-13	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2022-07-20	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2022-05-16	Premium	bought	Premium	Premium	Premium	Chief Operating Officer
2022-05-13	Premium	bought	Premium	Premium	Premium	-
2022-05-12	Premium	bought	Premium	Premium	Premium	-
2022-04-19	Premium	bought	Premium	Premium	Premium	-

DCTH - Delcath Systems, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for DCTH